H19 can inhibit HCC cell migration through Hnrnpu/PCAF/RNA Pol-II, and can also activate the miR-200 family by increasing histone acetylation, thereby inhibiting HCC metastasis [50]. Here, KAT2B is linked to hepatocellular carcinoma.